Clinical Trials Browser

indibulin × Clear all

NCT01113970 2013-01-30

Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT00591136 2012-07-19

Phase I Study of Indibulin in Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00591292 2012-07-19

Phase I Study in Advanced Solid Tumors

Phase 1 Unknown

Neoplasms

NCT00591383 2012-07-19

Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors

Phase 1 Unknown

Neoplasms

NCT00726687 2012-07-19

Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors

Phase 1/2 Unknown

Neoplasms